$FCHS

First Choice Healthcare Solutions, Inc.

CIK:0001416876|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenue
Revenue, net of discounts		$ 1,423		$ 5,456
Gross profit		1,423		5,456
Operating expenses
Compensation expense	96,802	143,578	199,053	255,241
Selling, general and administrative expenses	439,176	432,259	1,068,258	909,087
Total operating expenses	535,978	575,837	1,267,310	1,164,328
Operating loss	(535,978)	(574,414)	(1,267,310)	(1,158,872)
Other income (expenses)
Other Income (expense)	8,219		8,219
Gain (loss) on sale of equipment		(20,788)		(48,328)
Deposit written off	(101,746)		(101,746)
PPP Loan Forgiveness		471,300		471,300
Gain (loss) on Lease Termination	299,375		299,375
Interest expense, net	(6,681,244)	(515,534)	(7,385,781)	(1,301,429)
Total other income (expenses), net	(6,475,396)	(65,022)	(7,179,933)	(878,457)
Loss from continuing operations before income taxes	(7,011,374)	(639,436)	(8,447,243)	(2,037,329)
Income taxes expense (benefit)
Net loss	(7,011,374)	(639,436)	(8,447,243)	(2,037,329)
Preferred stock dividends
Net loss attributable to common shareholders	$ (7,011,374)	$ (639,436)	$ (8,447,243)	$ (2,037,329)
Basic and diluted loss per common share
Net loss per common share, basic	$ (0.21)	$ (0.02)	$ (0.26)	$ (0.06)
Net loss per common share, diluted	$ (0.21)	$ (0.02)	$ (0.26)	$ (0.06)
Weighted average number of common shares outstanding, basic	32,958,288	32,958,288	32,958,288	32,958,288
Weighted average number of common shares outstanding, diluted	32,958,288	32,958,288	32,958,288	32,958,288

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net loss	$ (8,447,243)	$ (2,037,329)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation	5,813	9,733
Loss on sale of assets		48,327
Forgiveness of PPP Loan		(471,300)
Interest expense	7,385,781	1,301,429
Deposits written off	101,746
Gain (loss) on lease termination	(299,375)
Changes in operating assets and liabilities:
Other current assets	(145,665)	11,403
Decrease in leased assets	482,383	195,484
(Decrease) Increase in accounts payable and accrued liabilities	732,506	694,968
Net cash used in operating activities	(184,054)	(247,285)
Cash flows from investing activities:
Proceeds from the sale of fixed assets		10,000
Net cash provided by investing activities		10,000
Cash flows from financing activities:
Interest Paid		(90,000)
Repayment of Notes Payable	(200,000)
Proceeds from issuance of convertible notes	385,000	455,454
Net cash provided by financing activities	185,000	365,454
Net change in cash	946	128,169
Cash, beginning of period	5,896	19,915
Cash, end of period	6,842	148,084
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Note Payable addition from OID
Common shares issued for convertible notes - inducement

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 6,842	$ 5,896
Other Current Assets	403	717
Total current assets	7,245	6,613
Property, plant and equipment, net	141,148	146,961
Operating lease right-of-use assets		3,350,511
Deposits	428,100	543,345
Total assets	576,493	4,047,430
Current liabilities:
Accounts payable and accrued expenses	4,426,068	13,115,035
Operating lease liabilities, current portion		382,121
Notes payable	5,658,513	27,177,660
Total current liabilities	10,084,581	40,674,816
Long term liabilities:
PPP loan payable
Operating lease liabilities, non-current portion		2,900,690
Total liabilities	10,084,581	43,575,506
Stockholders’ deficit:
Common stock, $0.001 par value, 100,000,000 shares authorized 32,958,288 and 32,958,288 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively	32,958	32,958
Additional paid-in capital	35,135,111	35,182,032
Treasury stock, 74,453 common shares, at cost
Accumulated deficit	(83,190,310)	(74,743,067)
Total stockholders’ deficit	(9,508,087)	(39,528,075)
Total liabilities and stockholders’ deficit	576,493	4,047,430
Series A Super Voting Preferred Stock [Member]
Stockholders’ deficit:
Preferred stock value
Series B Convertible Preferred Stock [Member]
Stockholders’ deficit:
Preferred stock value	1	1
Series C Preferred Stock [Member]
Stockholders’ deficit:
Preferred stock value	22,242,837
Series E Preferred Stock [Member]
Stockholders’ deficit:
Preferred stock value	$ 16,271,315